# Safety Study of Immune System Modulator for Autoimmune Diseases

> **NCT02243683** · PHASE1 · COMPLETED · sponsor: **Artax Biopharma Inc** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AX-024.HCl
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02243683
- **Lead sponsor:** Artax Biopharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-11
- **Final completion:** 2015-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243683, "Safety Study of Immune System Modulator for Autoimmune Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02243683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*